Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.505 USD | -0.43% | -5.00% | -6.02% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.02% | 401M | |
+9.88% | 118B | |
+10.15% | 106B | |
-11.83% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.55% | 15.97B | |
+6.51% | 14.03B | |
+15.95% | 11.67B |
- Stock Market
- Equities
- FATE Stock
- News Fate Therapeutics, Inc.
- Morgan Stanley Adjusts Price Target on Fate Therapeutics to $8 From $35, Maintains Equalweight Rating